References
- Aebi, H., 1983. Catalase. In: H.U. Bergmeyer, ed. Methods in enzymatic analysis. New York: Academic Press, 276–286.
- Ahmad, S.T., et al., 2012. Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation. Toxicology Letters, 208, 149–161.
- Chen, M., et al., 2010. Protective effects of hesperidin against oxidative stress of tert-butyl hydroperoxide in human hepatocytes. Food and Chemical Toxicology, 48, 2980–2987.
- Elbe, H., et al., 2015. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Human & Experimental Toxicology, 34, 100–113.
- Elmas, O., Erbas, O., and Yigitturk, G., 2016. The efficacy of Aesculus hippocastanum seeds on diabetic nephropathy in a streptozotocin-induced diabetic rat model. Biomedicine & Pharmacotherapy, 83, 392–396.
- Forbes, J.M., Fukami, K., and Cooper, M.E., 2007. Diabetic nephropathy: where hemodynamics meets metabolism. Experimental and Clinical Endocrinology & Diabetes, 115, 69–84.
- Goodarzi, M.T., et al., 2010. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. Journal of Clinical Laboratory Analysis, 24, 72–76.
- Ha, H., et al., 2008. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Research and Clinical Practice, 82, S42–S45.
- Hao, H.H., et al., 2012. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sciences, 91, 959–967.
- He, F.F., et al., 2015. Tumor necrosis factor-alpha and 8-hydroxy-2′-deoxyguanosine are associated with elevated urinary angiopoietin-2 level in type 2 diabetic patients with albuminuria. Kidney & Blood Pressure Research, 40, 355–365.
- Hills, C.E., and Squires, P.E., 2009. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. American Journal of Nephrology, 31, 68–74.
- International Diabetes Federation. 2015. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation. Available from: http://www.diabetesatlas.org/ [Accessed 15 July 2016].
- Ji, X., et al., 2016. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway. Molecular and Cellular Endocrinology, 437, 268–279.
- Kanter, M., et al., 2010. Protective effects of irbesartan and alpha lipoic acid in STZ-induced diabetic nephropathy in rats. Renal Failure, 32, 498–505.
- Kitada, M., et al., 2011. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes, 60, 634–643.
- Lawrence, R.A. and Burk, R.F., 1976. Glutathione peroxidase activity in selenium-deficient rat liver. Biochemical and Biophysical Research Communications, 71, 952–958.
- Li, C., et al., 2010. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway. European Journal of Pharmacology, 649, 382–389.
- Lowry, O.H., et al., 1951. Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry, 193, 265–275.
- Mahmoud, A.M., et al., 2012. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. Journal of Diabetes and its Complications, 26, 483–490.
- Memisoğullan, R., et al., 2003. Antioxidant status and lipid peroxidation in type ıı diabetes mellitus. Cell Biochemistry and Function, 21, 291–296.
- Mizuno, S. and Nakamura, T., 2004. Suppressions of chronic glomerular injuries and TGF-β1 production by HGF in attenuation of murine diabetic nephropathy. American Journal of Physiology – Renal Physiology, 286, 134–143.
- Nauseef, W.M., 2008. Biological roles for the NOX family NADPH oxidases. The Journal of Biological Chemistry, 283, 16961–16965.
- Pal, P.B., Sinha, K., and Sil, P.C., 2014. Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats. PLoS One, 9, e107220.
- Pan, H.Z., et al., 2010. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetologica, 47, 71–76.
- Placer, Z.A., Cushmanni, L.L., and Johnson, B.C., 1966. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Analytical Biochemistry, 16, 359–364.
- Qi, M.Y., et al., 2011. Protective effect of ıcariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β 1 and type IV collagen expression in rats. Journal of Ethnopharmacology, 138, 731–736.
- Sahu, B.D., et al., 2013. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine, 20, 453–460.
- Sedlak, J. and Lindsay, R.H.C., 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Analytical Biochemistry, 25, 192–205.
- Sefi, M., et al., 2012. Artemisia campestris leaf extract alleviates early diabetic nephropathy in rats by inhibiting protein oxidation and nitric oxide end products. Pathology, Research and Practice, 208, 157–162.
- Serdar, M., et al., 2012. Comparison of 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy. Free Radical Research, 46, 1291–1295.
- Seif, H.S.A., 2012. Protective effects of rutin and hesperidin against doxorubicin-ınduced nephrotoxicity. Beni-Suef University Journal of Applied Sciences, 1, 1–18.
- Sonawane, R.D., et al., 2010. Amelioration of STZ-induced type 1 diabetic nephropathy by aqueous extract of Enicostemma littorale Blume and swertiamarin in rats. Molecular and Cellular Biochemistry, 340, 1–6.
- Sun, Y.M., et al., 2013. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochemical and Biophysical Research Communications, 433, 359–361.
- Sun, Y., Oberley, L.W., and Li, Y., 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry, 34, 497–500.
- Wu, L., et al., 2012. The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats. Molecular Biology Reports, 39, 9085–9093.